Document is current
Any future updates will be listed below
-
Authors
Dicker, Dror http://orcid.org/0000-0001-8546-6245
Kornboim, Batya
Bachrach, Rakefet
Shehadeh, Naim
Potesman-Yona, Shani
Segal-Lieberman, Gabriella
-
Funding
Funding for this research was provided by:
Novo Nordisk (NA)
- License Information
-
More Information
Article History
Received: 16 December 2019
Accepted: 8 September 2020
First Online: 21 October 2020
Ethics approval and consent to participate
: All respondents provided electronic informed consent prior to initiation of the screening questions and survey. The questionnaires were approved by the local Rabin Medical Center ethics committee.
: Not applicable.
: D. D. reports personal fees for medical lectures and consultations from Novo Nordisk, during the conduct and steering of the study, and personal fees for medical lectures and consultations from Teva, outside the submitted work. N. S. reports personal fees for medical lectures from Novo Nordisk, Eli Lilly, Boehringer Ingelheim and Sanofi, personal fees for consultations from Novo Nordisk, Eli Lilly, Boehringer Ingelheim and Sanofi, and grants for supporting patient and staff education from Novo Nordisk, Eli Lilly, Boehringer Ingelheim and Sanofi, outside the submitted work. S. P.-Y. was an employee of Novo Nordisk during study conduct and manuscript development. B. K., R. B. and G. S.-L. disclose no conflicts of interest.
